A message from the Guest Editor and MauiDerm Program Director, George Martin, MD Dear Colleagues: The 2019 edition of the MauiDerm for Dermatologists meeting had a variety of clinical and scientific data presented not only at the podium, but in its poster sessions as well. A wide range of clinically relevant material was presented in poster
by Daniel P. Friedmann, MD, FAAD; Vineet Mishra, MD, FAAD; and Trevor Batty, BS Dr. Friedmann is with the Westlake Dermatology Clinical Research Center at Westlake Dermatology & Cosmetic Surgery in Austin, Texas. Dr. Mishra is with the Division of Dermatology and Cutaneous Surgery at the University of Texas Health Science Center at San Antonio
by Deganit Barak-Shinar, PhD, and Lawrence J. Green, MD Dr. Barak-Shinar is Vice President of Clinical, Regulation and Quality Assurance at Kamedis Ltd. in Tel-Aviv, Israel. Dr. Green is Associate Clinical Professor of Dermatology at The George Washington University School of Medicine in Washington, DC. Funding: This study was wholly funded by Kamedis Ltd. Disclosures:
by Ryan R. Riahi, MD, and Philip R. Cohen, MD Dr. Riahi is with DermSurgery Associates, Houston, Texas; and Dr. Cohen is with the Department of Dermatology, University of California San Diego, La Jolla, California. J Clin Aesthet Dermatol. 2017;10(7):23–27 Funding: No funding was provided. Disclosures: The authors have no conflicts of interest relevant to
James Q. Del Rosso, DO, Dermatology Residency Program Director, Valley Hospital Medical Center, Las Vegas, Nevada Disclosure: Dr. Del Rosso is a consultant, speaker, and/or researcher for Allergan, Coria, Galderma, Graceway, Intendis, Leo Pharma, Medicis, Onset Therapeutics, Ortho Dermatology, PharmaDerm, Promius, Quinnova, Ranbaxy, SkinMedica, Stiefel, Triax, Unilever, and Warner Chilcott.